Filing Flows › Comparisons › SON vs DSS
Sonoco Products vs DSS: SON and DSS compared
Sonoco Products is the larger company: $2.0B of revenue in its latest quarter (Q3 2026) against $3.6M for DSS (Q2 2026). Sonoco Products is growing faster (-4% against -32% a year earlier). Sonoco Products is more profitable, with an operating margin of -31.2% against -105.0%.
Where the money goes: SON and DSS
Sonoco Products (SON) · Q3 2026
Sonoco Products, Q3 2026: revenue $2.0B (-4% year over year), operating margin -31.2%, net loss $732M, operating cash flow $285M. The chart follows the revenue to costs, profit and cash.
DSS (DSS) · Q2 2026
DSS, Q2 2026: revenue $3.6M (-32% year over year), operating margin -105.0%, net loss $5.0M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
| Sonoco Products (SON) | DSS (DSS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $2.0B | $3.6M |
| Revenue growth, Y/Y | -4% | -32% |
| Operating margin | -31.2% | -105.0% |
| Net earnings | −$732M | −$5.0M |
| Net margin | -35.8% | -139.7% |
| Operating cash flow | $285M | −$1.9M |
| Free cash flow | $222M | — |
| Market value | $5.0B | — |
| Analysts’ mean target | $57.12 | — |
Where the revenue comes from
DSS
- Printed Products Revenue Information: $3.3M (91%)
- Rental: $245K (7%)
- Commission: $92K (3%)
- Biotechnology: $3K (0%)
Questions
Which is bigger, Sonoco Products or DSS?
Sonoco Products is the larger company: $2.0B of revenue in its latest quarter (Q3 2026) against $3.6M for DSS (Q2 2026).
Is Sonoco Products or DSS growing faster?
Sonoco Products is growing faster (-4% against -32% a year earlier).
Which is more profitable, Sonoco Products or DSS?
Sonoco Products is more profitable, with an operating margin of -31.2% against -105.0%.
More: Sonoco Products earnings · how Sonoco Products makes money · DSS earnings · how DSS makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.